DOCSLIB.ORG

TOX-27: Riddelliine (CASRN 23246-96-0)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TOX-27: Riddelliine (CASRN 23246-96-0) National Toxicology Program Toxicity Report Series Number 27 NTP Technical Report on Toxicity Studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344/N Rats and B6C3F1 Mice Po C. Chan, PhD, Study Scientist National Toxicology Program Post Office Box 12233 Research Triangle Park, NC 27709 NIH Publication 94-3350 December 1993 United States Department of Health and Human Services Public Health Service National Institutes of Health Note to the Reader The National Toxicology Program (NTP) is made up of four charter agencies of the United States Department of Health and Human Services (DHHS): • the National Cancer Institute (NCI) of the National Institutes of Health; • the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health; • the National Center for Toxicological Research (NCTR) of the Food and Drug Administration; and • the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control. In July 1981, the Carcinogenesis Bioassay Testing Program was transferred from NCI to NIEHS. NTP coordinates the relevant Public Health Service programs, staff, and resources that are concerned with basic and applied research and with biological assay development and validation. NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. To carry out its mission, NTP designs and conducts studies to characterize and evaluate the toxicologic potential of selected chemicals in laboratory animals (usually two species, rats and mice). Chemicals selected for NTP toxicology studies are chosen primarily on the bases of human exposure, level of production, and chemical structure. Selection per se is not an indicator of a chemical's toxic potential. The studies described in this toxicity study report were performed under the direction of NIEHS and were conducted in compliance with NTP chemical health and safety requirements. These studies met or exceeded all applicable federal, state, and local health and safety regulations. Animal care and use were in accord and compliance with the Public Health Service Policy on Humane Care and Use of Animals. Single copies of this report are available without charge, while supplies last, from the NTP Public Information Office (telephone number 919/541-3991). NTP Public Information Office NIEHS Post Office Box 12233 Research Triangle Park, NC 27709 National Toxicology Program Toxicity Report Series Number 27 NTP Technical Report on Toxicity Studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344/N Rats and B6C3F1 Mice Po C. Chan, PhD, Study Scientist National Toxicology Program Post Office Box 12233 Research Triangle Park, NC 27709 NIH Publication 94-3350 December 1993 United States Department of Health and Human Services Public Health Service National Institutes of Health RIDDELLIINE, NTP TOXICITY REPORT NUMBER 27 2 CONTRIBUTORS This NTP report on the toxicity studies of riddelliine was based primarily on 2-week studies that took place in November 1986 and 13-week studies that began in March 1987 and ended in September 1987 at SRI International, Menlo Park, CA. National Toxicology Program SRI International Evaluated experiment, interpreted results, and Principal contributors reported findings James R. Hill, PhD Po C. Chan, PhD, Study Scientist Jon B. Reid, PhD John R. Bucher, PhD Principal Investigators Leo T. Burka, PhD Richard Becker Rajendra S. Chhabra, PhD R. Long Michael P. Dieter, PhD Earl Meierhenry Michael R. Elwell, DVM, PhD Jon Mirsalis Joel Mahler, DVM Ron Spanggord Robert R. Maronpot, DVM H. B. Matthews, PhD Experimental Pathology Laboratories, Morrow B. Thompson, DVM, PhD Inc Gregory S. Travlos, PhD Provided pathology quality assessment Errol Zeiger, PhD John Peckham, DVM, MS, PhD Gary Riley, MVSc, PhD Coordinated report preparation Jane M. Lambert, BS Environmental Health Research and Edison McIntyre, BS Testing, Inc Kristine L. Witt, MS Provided sperm morphology and vaginal cytology Oak Ridge Associated Universities evaluation Teresa Cocanougher, BA NTP Pathology Working Group Dushant K. Gulati, PhD Evaluated slides and prepared pathology report Susan Russell, BA John C. Seely, DVM, Chair PATHCO, Inc. Analytical Sciences, Inc John Cullen, VMD, PhD Provided statistical analyses North Carolina State University Steven Seilkop, MS Michael P. Elwell, DVM, PhD Janet Teague, MS National Toxicology Program Seiichi Imoto, DVM, PhD (Observer) Biotechnical Services, Inc Shin Nippon Biomedical Laboratories, Provided toxicity report preparation Japan Janet L. Elledge, BA, Principal Investigator Margarita M. McDonald, DVM, PhD Chad J. Fitz, MA National Toxicology Program Paula C. Higginson, BA William F. MacKenzie, DVM, MS Theresa King-Hunter, BS Experimental Pathology Laboratories, Jennifer Rector, MAP Inc A.W. Macklin, DVM, PhD Burroughs Wellcome Research Laboratories 3 RIDDELLIINE, NTP TOXICITY REPORT NUMBER 27 TABLE OF CONTENTS ABSTRACT.......................................................................................................................... 5 PEER REVIEW PANEL........................................................................................................ 10 SUMMARY OF PEER REVIEW COMMENTS .......................................................................... 11 INTRODUCTION................................................................................................................. 13 Physical Properties, Occurrence, and Exposure .......................................................... 13 Disposition and Metabolism ....................................................................................... 14 Toxicity....................................................................................................................... 16 Study Rationale and Design........................................................................................ 21 MATERIALS AND METHODS .............................................................................................. 23 Procurement and Characterization of Riddelliine ........................................................ 23 Dose Formulations ..................................................................................................... 24 Toxicity Study Designs ............................................................................................... 24 Supplemental Evaluations.......................................................................................... 26 Genetic Toxicity Studies ............................................................................................. 32 Statistical Methods ..................................................................................................... 35 Quality Assurance ...................................................................................................... 38 RESULTS .......................................................................................................................... 39 2-Week Gavage Study in F344/N Rats........................................................................ 39 13-Week Gavage Study in F344/N Rats...................................................................... 43 2-Week Gavage Study in B6C3F1 Mice ....................................................................... 65 13-Week Gavage Study in B6C3F1 Mice ..................................................................... 67 Mating Trial Results ................................................................................................... 79 Genetic Toxicity .......................................................................................................... 80 DISCUSSION ..................................................................................................................... 87 REFERENCES ................................................................................................................... 95 APPENDIXES Appendix A Organ Weights and Organ-Weight-to-Body-Weight Ratios ................... A-1 Appendix B Hematology and Clinical Chemistry Results ........................................B-1 Appendix C Reproductive Tissue Evaluations and Estrous Cycle Characterization ...................................................C-1 Appendix D Genetic Toxicology .............................................................................D-1 RIDDELLIINE, NTP TOXICITY REPORT NUMBER 27 4 5 RIDDELLIINE, NTP TOXICITY REPORT NUMBER 27 Riddelliine Molecular Formula C18H23NO6 CAS Number 23246-96-0 Molecular Weight 349.4 Synonyms 13,19-didehydro-12,18-dihydroxy senecionan-11,16-dione; trans-15-ethylidine-12b-hydroxy-12a-hydroxymethyl-13- methylenesenec-1-enine; 3-ethylidine-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-6- (hydroxymethyl)-5-methylene(1,6)di-oxacyclododecino (2,3,4-gh)-pyrrolizidine-2,7-dione ABSTRACT Riddelliine is a naturally occurring pyrrolizidine alkaloid, a class of compounds occurring in rangeland plants of the genera Crotalaria, Amsinckia, and Senecio. Two- week and 13-week rodent toxicity studies of riddelliine were conducted because riddelliine can be a contaminant of foodstuffs, such as meat, grains, seeds, milk, herbal tea, and honey. In addition to histopathology, evaluations included clinical pathology and reproductive toxicity. In vitro genetic toxicity studies included assessments of mutagenicity in Salmonella typhimurium and
Load more

Recommended publications
  • Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2020–2024
    IARC Monographs on the Identification of Carcinogenic Hazards to Humans Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 Report of the Advisory Group to Recommend Priorities for the IARC Monographs during 2020–2024 CONTENTS Introduction ................................................................................................................................... 1 Acetaldehyde (CAS No. 75-07-0) ................................................................................................. 3 Acrolein (CAS No. 107-02-8) ....................................................................................................... 4 Acrylamide (CAS No. 79-06-1) .................................................................................................... 5 Acrylonitrile (CAS No. 107-13-1) ................................................................................................ 6 Aflatoxins (CAS No. 1402-68-2) .................................................................................................. 8 Air pollutants and underlying mechanisms for breast cancer ....................................................... 9 Airborne gram-negative bacterial endotoxins ............................................................................. 10 Alachlor (chloroacetanilide herbicide) (CAS No. 15972-60-8) .................................................. 10 Aluminium (CAS No. 7429-90-5) .............................................................................................. 11
    [Show full text]
  • Clinical Biochemistry of Hepatotoxicity
    linica f C l To o x l ic a o n r l o u g Singh, J Clinic Toxicol 2011, S:4 o y J Journal of Clinical Toxicology DOI: 10.4172/2161-0495.S4-001 ISSN: 2161-0495 ReviewResearch Article Article OpenOpen Access Access Clinical Biochemistry of Hepatotoxicity Anita Singh1, Tej K Bhat2 and Om P Sharma2* 1CSK Himachal Pradesh, Krishi Vishva Vidyalaya, Palampur (HP) 176 062, India 2Biochemistry Laboratory, Indian Veterinary Research Institute, Regional Station, Palampur (HP) 176 061, India Abstract Liver plays a central role in the metabolism and excretion of xenobiotics which makes it highly susceptible to their adverse and toxic effects. Liver injury caused by various toxic chemicals or their reactive metabolites [hepatotoxicants) is known as hepatotoxicity. The present review describes the biotransformation of hepatotoxicants and various models used to study hepatotoxicity. It provides an overview of pathological and biochemical mechanism involved during hepatotoxicity together with alteration of clinical biochemistry during liver injury. The review has been supported by a list of important hepatotoxicants as well as common hepatoprotective herbs. Keywords: Hepatotoxicity; Hepatotoxicant; In Vivo models; In Vitro production of bile thus leading to the body’s inability to flush out the models; Pathology; Alanine aminotransferase; Alkaline phosphatase; chemicals through waste. Smooth endoplasmic reticulum of the liver is Bilirubin; Hepatoprotective the principal ‘metabolic clearing house’ for both endogenous chemicals like cholesterol, steroid hormones, fatty acids and proteins, and Introduction exogenous substances like drugs and alcohol. The central role played by liver in the clearance and transformation of chemicals exposes it to Hepatotoxicity refers to liver dysfunction or liver damage that is toxic injury [4].
    [Show full text]
  • National Center for Toxicological Research
    National Center for Toxicological Research Annual Report Research Accomplishments and Plans FY 2015 – FY 2016 Page 0 of 193 Table of Contents Preface – William Slikker, Jr., Ph.D. ................................................................................... 3 NCTR Vision ......................................................................................................................... 7 NCTR Mission ...................................................................................................................... 7 NCTR Strategic Plan ............................................................................................................ 7 NCTR Organizational Structure .......................................................................................... 8 NCTR Location and Facilities .............................................................................................. 9 NCTR Advances Research Through Outreach and Collaboration ................................... 10 NCTR Global Outreach and Training Activities ............................................................... 12 Global Summit on Regulatory Science .................................................................................................12 Training Activities .................................................................................................................................14 NCTR Scientists – Leaders in the Research Community .................................................. 15 Science Advisory Board ...................................................................................................
    [Show full text]
  • CHEMICAL PRODUCTS CORPORATION April 20, 2018 Via
    CHEMICAL PRODUCTS CORPORATION CARTERSVILLE, GEORGIA 30120 POST OFFICE BOX 2470 TELEPHONE 770-382-2144 FAX 770-386-6053 April 20, 2018 Via Certified Mail and Electronic Mail ([email protected]) USEPA Headquarters William Jefferson Clinton Federal Building 1200 Pennsylvania Avenue, NW Mail Code: 2821T Washington, DC 20460 Subject: Information Quality Guidelines (IQG) identifier: RFC #17003 Additional Information demonstrating that National Toxicology Program Technical Report 494 should not be the basis for provisional screening values presented in Appendix A of “Provisional Peer-Reviewed Toxicity Values for 9,10- Anthraquinone (CASRN 84-65-1)”, EPA/690/R-11/007F, Final 2-17-2011 or the screening levels for “Anthraquinone, 9,10-” in EPA’s Regional Screening Level Tables Dear Sir or Madam: This letter contains additional information to supplement the Request for Correction submitted by Chemical Products Corporation (CPC) on April 6, 2018, assigned Information Quality Guidelines Identifier RFC #17003. The contents of this letter provide yet another sufficient reason to conclude that the National Toxicology Program (NTP) peer review panel which accepted the conclusions presented in NTP Technical Report 494 (TR-494) were not presented accurate information, thus, the peer review panel was unable to render a sound scientific judgment regarding the conclusions presented in TR-494. The peer review of TR- 494 does not meet the “sound and objective scientific practices” REQUEST FOR CORRECTION SUBMITTED BY CHEMICAL PRODUCTS CORPORATION Additional Information IQG identifier: RFC #17003 Page 2 of 5 April 20, 2018 requirement contained in the EPA Guidelines and should not be accepted by EPA as a valid peer review.
    [Show full text]
  • Hepatic Veno-Occlusive Disease As a Result of a Traditional Remedy: Confirmation of Toxic Pyrrolizidine Alkaloids As the Cause
    676 ORIGINAL ARTICLE J Clin Pathol: first published as 10.1136/jcp.55.9.676 on 1 September 2002. Downloaded from Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique M Zuckerman, V Steenkamp, M J Stewart ............................................................................................................................. J Clin Pathol 2002;55:676–679 See end of article for Background/Aims: A child presented with hepatic veno-occlusive disease after having been adminis- authors’ affiliations tered a short course of treatment with a traditional herbal remedy. The child subsequently died. Post- ....................... mortem liver histology confirmed the diagnosis. This study aimed to investigate the hypothesis that the Correspondence to: herbal remedy was the cause of veno-occlusive disease. Dr M J Stewart, Department Methods: Extracts of the traditional remedy were analysed by colorimetry and gas chromatography/ of Chemical Pathology, mass spectrometry. Cultured hepatocytes were treated with an extract of the plant material and exam- University of the ined for morphological changes. Witwatersrand Medical Results: The screening analyses indicated the presence of toxic pyrrolizidine alkaloids, which were School, 7 York Road, Parktown 2193, Gauteng, later confirmed by gas chromatography/mass spectrometry. The cell studies indicated dose related South Africa; toxicity, with necrosis at high concentrations and apoptosis and abnormalities of the cytoskeleton at [email protected] lower concentrations. Accepted for publication 5 Conclusions: The simple screening techniques used allowed rapid confirmation of the presence of September 2001 toxic pyrrolizidines in the remedy. The in vitro method confirmed the toxicity of herbal extracts to hepa- ......................
    [Show full text]
  • D. SENECIO SPECIES and RIDDELLIINE 1. Exposure Data
    D. SENECIO SPECIES AND RIDDELLIINE 1. Exposure Data 1.1 Origin, type and botanical data (Molyneux et al., 1991) Senecio riddellii (Asteraceae) (Riddell groundsel) is a grey-white half-shrub, 30–90 cm tall with pinnatifid and relatively hairless leaves, revealing its bright green leaf colour. It has bright yellow flowers on the stems at about the same height above the ground. This gives the plant a flat-topped appearance when in bloom. It produces flowers in late summer to early autumn and dies back to ground level after the first frost. It grows in dry, sandy soils and its roots are long and about as thick as a lead pencil. Senecio longilobus (also known as woolly groundsel and thread-leaf groundsel) is a shrubby, erect, branched, leafy plant, 30–60 cm tall. It has narrowly linear leaves which are thick, white, and occasionally pinnately lobed, up to 10 cm long. The composite yellow flower heads contain numerous clusters. In North America, this is a common plant with a range extending from Colorado to Utah, south to Texas and Mexico (Kingsbury, 1964). 1.2 Use The ‘bush tea’ used in Jamaica to treat children for a cold an a herbal tea that is popular in the south-west USA, gordolobo yerba, may contain riddelliine (Stillman et al., 1977a; Huxtable, 1980; National Toxicology Program, 2002). 1.3 Chemical constituents The plants (ragworts) from which riddelliine and other pyrrolizidine alkaloids are isolated are found in the rangelands of the western USA. Cattle, horses and, less commonly, sheep that ingest these plants can succumb to their toxic effects (called pyrro- lizidine alkaloidosis).
    [Show full text]
  • In Vitro Biotransformation of Pyrrolizidine Alkaloids in Different Species
    Archives of Toxicology https://doi.org/10.1007/s00204-017-2114-7 TOXICOKINETICS AND METABOLISM In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: Microsomal degradation Franziska Kolrep1 · Jorge Numata1 · Carsten Kneuer1 · Angelika Preiss‑Weigert1 · Monika Lahrssen‑Wiederholt1 · Dieter Schrenk2 · Anja These1 Received: 20 September 2017 / Accepted: 8 November 2017 © The Author(s) 2017. This article is an open access publication Abstract Pyrrolizidine alkaloids (PA) are secondary metabolites of certain flowering plants. The ingestion of PAs may result in acute and chronic effects in man and livestock with hepatotoxicity, mutagenicity, and carcinogenicity being identified as predominant effects. Several hundred PAs sharing the diol pyrrolizidine as a core structure are formed by plants. Although many congeners may cause adverse effects, differences in the toxic potency have been detected in animal tests. It is generally accepted that PAs themselves are biologically and toxicologically inactive and require metabolic activation. Consequently, a strong relationship between activating metabolism and toxicity can be expected. Concerning PA susceptibility, marked differences between species were reported with a comparatively high susceptibility in horses, while goat and sheep seem to be almost resistant. Therefore, we investigated the in vitro degradation rate of four frequently occurring PAs by liver enzymes present in S9 fractions from human, pig, cow, horse, rat, rabbit, goat, and sheep liver. Unexpectedly, almost no metabolic degradation of any PA was observed for susceptible species such as human, pig, horse, or cow. If the formation of toxic metabolites represents a crucial bioactivation step, the found inverse conversion rates of PAs compared to the known susceptibility require further investigation.
    [Show full text]
  • Pyrrolizidine Alkaloids: Biosynthesis, Biological Activities and Occurrence in Crop Plants
    molecules Review Pyrrolizidine Alkaloids: Biosynthesis, Biological Activities and Occurrence in Crop Plants Sebastian Schramm, Nikolai Köhler and Wilfried Rozhon * Biotechnology of Horticultural Crops, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Liesel-Beckmann-Straße 1, 85354 Freising, Germany; [email protected] (S.S.); [email protected] (N.K.) * Correspondence: [email protected]; Tel.: +49-8161-71-2023 Academic Editor: John C. D’Auria Received: 20 December 2018; Accepted: 29 January 2019; Published: 30 January 2019 Abstract: Pyrrolizidine alkaloids (PAs) are heterocyclic secondary metabolites with a typical pyrrolizidine motif predominantly produced by plants as defense chemicals against herbivores. They display a wide structural diversity and occur in a vast number of species with novel structures and occurrences continuously being discovered. These alkaloids exhibit strong hepatotoxic, genotoxic, cytotoxic, tumorigenic, and neurotoxic activities, and thereby pose a serious threat to the health of humans since they are known contaminants of foods including grain, milk, honey, and eggs, as well as plant derived pharmaceuticals and food supplements. Livestock and fodder can be affected due to PA-containing plants on pastures and fields. Despite their importance as toxic contaminants of agricultural products, there is limited knowledge about their biosynthesis. While the intermediates were well defined by feeding experiments, only one enzyme involved in PA biosynthesis has been characterized so far, the homospermidine synthase catalyzing the first committed step in PA biosynthesis. This review gives an overview about structural diversity of PAs, biosynthetic pathways of necine base, and necic acid formation and how PA accumulation is regulated. Furthermore, we discuss their role in plant ecology and their modes of toxicity towards humans and animals.
    [Show full text]
  • Current Knowledge and Perspectives of Pyrrolizidine Alkaloids in Pharmacological Applications: a Mini-Review
    molecules Review Current Knowledge and Perspectives of Pyrrolizidine Alkaloids in Pharmacological Applications: A Mini-Review Xianqin Wei 1,*, Weibin Ruan 1 and Klaas Vrieling 2 1 Institute of Entomology, College of Life Sciences, Nankai University, Tianjin 300071, China; [email protected] 2 Plant Science and Natural Products, Institute of Biology, Leiden University, Sylviusweg 72, P.O. Box 9505, 2300 RA Leiden, The Netherlands; [email protected] * Correspondence: [email protected] or [email protected] Abstract: Pyrrolizidine alkaloids (PAs) are a widespread group of secondary metabolites in plants. PAs are notorious for their acute hepatotoxicity, genotoxicity and neurological damage to humans and animals. In recent decades, the application of PAs for beneficial biological activities to cure disease has drawn greater attention. Here, we review the current knowledge regarding the pharmacological properties of PAs and discuss PAs as promising prototypes for the development of new drugs. Keywords: plant secondary metabolites; pharmacy; alkaloids; herb medicine; defense; regulations 1. Introduction Pyrrolizidine alkaloids (PAs) are an important group of secondary metabolites in Citation: Wei, X.; Ruan, W.; Vrieling, plants [1,2]. More than 500 different PAs were identified in more than 6000 plant species K. Current Knowledge and to date [1,3]. PAs have been identified in Apocynaceae (Alafia, Aristeguietia, Brachyglottis, Perspectives of Pyrrolizidine Cacalia, Eupatorium, Ligularia, Pittocaulon, Senecio and Tephroseris), Boraginaceae (Anchusa, Alkaloids in Pharmacological Borago, Cynoglossum, Echium, Heliotropium, Lithospermum, Onosma, Rindera and Solenanthus), Applications: A Mini-Review. Convolvulaceae (Argyreia), Fabaceae (Castanospermum and Crotalaria), Hyacinthaceae (Mus- Molecules 2021, 26, 1970. https:// cari and Scilla), Orchidaceae (Cremastra and Liparis), and Santalaceae (Amphorogyne and doi.org/10.3390/molecules26071970 Osyris)[4–6].
    [Show full text]
  • Public Statement on Contamination of Herbal Medicinal Products
    31 May 2016 EMA/HMPC/328782/2016 Committee on Herbal Medicinal Products (HMPC) Public statement on contamination of herbal medicinal products/traditional herbal medicinal products1 with pyrrolizidine alkaloids Transitional recommendations for risk management and quality control Discussion in Working Party on European Union Monographs and April 2016 European Union List (MLWP) Adoption by Committee on Herbal Medicinal Products (HMPC) 31 May 2016 Keywords Herbal medicinal products; HMPC; pyrrolizidine alkaloids; transitional recommendations for risk management and quality control 1 Throughout the document the term Herbal Medicinal Products (HMPs) includes Traditional Herbal Medicinal Products as defined in Dir. 2001/83/EC 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ......................................................................................... 2 1. Background ............................................................................................. 3 2. Brief review of toxicological data ............................................................ 4 2.1. Acute and subchronic toxicity of PAs ....................................................................... 4 2.2. Genotoxicity .......................................................................................................
    [Show full text]
  • Chemical Ecology Example 1. Pyrrolizidine Alkaloids (Pas)
    Alkaloids Part 2 Chemical Ecology p. 1 Alkaloids Part 2: Chemical Ecology Example 1. Pyrrolizidine Alkaloids (PAs) - Senecionine-N-oxides Background - basic structural type, but many variations - occurrence in plants in Compositae, Boragincaceae, Orchidaceae - extremely toxic to both mammals and insects but complex interactions - documented co-evolution with specialist insects, and sophisticated use of plant defenses by insects Biosynthesis Senecionine-N-oxide synthesized from two separate pathways/moieties - necine moiety, from arginine via putrescine (decarboxylate, condense, cyclize) - dicarboxylic acid moiety, from isoleucine => both form the macrocyclic diester = senecionine - key enzyme: homospermine synthase. Evolved independently at least four time - different plant families - from deoxyhypusine synthase, and enzyme of primary metabolism (activates eukaryotic translation initiation factor eIF5A) - five distinct structural types, that vary in macrocyclic diester bridge component Pyrrolizidine alkaloid localization and transport - root synthesis of senecionine, then transported to shoot - final accumulation of alkaloids is in flowers and shoot apex - further biochemical elaboration and structural diversification (decoration of macrocycle) occurs in shoot - population differentiation (diverse mixtures of pyrrolizidine alkaloids in different plant populations) - > variable target for pests. Pyrrolizidine Alkaloid Toxicity and its Avoidance - PA-containing plants are generally avoided by herbivores ( bitter taste, toxicity) - N-oxide
    [Show full text]
  • The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line Heparg
    foods Article The Food Contaminants Pyrrolizidine Alkaloids Disturb Bile Acid Homeostasis Structure-Dependently in the Human Hepatoma Cell Line HepaRG Josephin Glück 1, Marcus Henricsson 2, Albert Braeuning 1 and Stefanie Hessel-Pras 1,* 1 Department of Food Safety, German Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589 Berlin, Germany; [email protected] (J.G.); [email protected] (A.B.) 2 Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden; [email protected] * Correspondence: [email protected]; Tel.: +49-30-18412-25203 Abstract: Pyrrolizidine alkaloids (PAs) are a group of secondary plant metabolites being contained in various plant species. The consumption of contaminated food can lead to acute intoxications in humans and exert severe hepatotoxicity. The development of jaundice and elevated bile acid concentrations in blood have been reported in acute human PA intoxication, indicating a connection between PA exposure and the induction of cholestasis. Additionally, it is considered that differences in toxicity of individual PAs is based on their individual chemical structures. Therefore, we aimed to elucidate the structure-dependent disturbance of bile acid homeostasis by PAs in the human hepatoma cell line HepaRG. A set of 14 different PAs, including representatives of all major structural characteristics, namely, the four different necine bases retronecine, heliotridine, otonecine and platynecine and different grades of esterification, was analyzed in regard to the expression of genes Citation: Glück, J.; Henricsson, M.; Braeuning, A.; Hessel-Pras, S. The involved in bile acid synthesis, metabolism and transport.
    [Show full text]